...
search icon
hypd-img

Hyperion DeFi, Inc., Common Stock

HYPD

NAQ

$7.625

+$0.17

(2.28%)

1D

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$30.54M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
496.96K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.85 L
$75.2 H
$7.625

About Hyperion DeFi, Inc., Common Stock

Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi; and agreement with Formosa Pharmaceuticals. Inc. for Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in New York, New York. more

Returns

Data is not properly formatted.

Financials

Dec '21Dec '22Dec '23Dec '24
Total Revenue14.00M-3.79K57.34K[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":0.03,"profit":true},{"date":"2024-12-31","value":0.41,"profit":true}]
Cost of Revenue1.60M-16.00K3.93M[{"date":"2021-12-31","value":40.74,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":0.41,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit12.40M-(12.22K)(3.87M)[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-0.1,"profit":false},{"date":"2024-12-31","value":-31.21,"profit":false}]
Gross Margin88.57%-(322.63%)(6749.50%)[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-364.26,"profit":false},{"date":"2024-12-31","value":-7620.4,"profit":false}]
Operating Expenses25.42M26.91M25.39M44.87M[{"date":"2021-12-31","value":56.66,"profit":true},{"date":"2022-12-31","value":59.98,"profit":true},{"date":"2023-12-31","value":56.6,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(13.02M)(26.91M)(25.41M)(48.74M)[{"date":"2021-12-31","value":-1302052700,"profit":false},{"date":"2022-12-31","value":-2691151500,"profit":false},{"date":"2023-12-31","value":-2540644600,"profit":false},{"date":"2024-12-31","value":-4873822500,"profit":false}]
Total Non-Operating Income/Expense(143.10K)(2.40M)(3.53M)(3.31M)[{"date":"2021-12-31","value":-14310000,"profit":false},{"date":"2022-12-31","value":-239637400,"profit":false},{"date":"2023-12-31","value":-353288900,"profit":false},{"date":"2024-12-31","value":-331061500,"profit":false}]
Pre-Tax Income(12.78M)(28.01M)(27.26M)(49.82M)[{"date":"2021-12-31","value":-1277838700,"profit":false},{"date":"2022-12-31","value":-2801115700,"profit":false},{"date":"2023-12-31","value":-2726109600,"profit":false},{"date":"2024-12-31","value":-4981843300,"profit":false}]
Income Taxes----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(12.78M)(28.01M)(27.26M)(49.82M)[{"date":"2021-12-31","value":-1277838700,"profit":false},{"date":"2022-12-31","value":-2801115700,"profit":false},{"date":"2023-12-31","value":-2726109600,"profit":false},{"date":"2024-12-31","value":-4981843300,"profit":false}]
Income From Discontinued Operations----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(12.78M)(28.01M)(27.26M)(49.82M)[{"date":"2021-12-31","value":-1277838700,"profit":false},{"date":"2022-12-31","value":-2801115700,"profit":false},{"date":"2023-12-31","value":-2726109600,"profit":false},{"date":"2024-12-31","value":-4981843300,"profit":false}]
EPS (Diluted)(40.99)-(107.66)(61.97)[{"date":"2021-12-31","value":-4098.9,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-10765.58,"profit":false},{"date":"2024-12-31","value":-6197.03,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

HYPD
Cash Ratio 0.26
Current Ratio 0.34

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

HYPD
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

HYPD
Debt Ratio Lower is generally better. Negative is bad. 2.62
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -1.62

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

HYPD
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
EV/R 0.00
EV/Ebitda NM

FAQs

What is Hyperion DeFi, Inc. share price today?

Hyperion DeFi, Inc. (HYPD) share price today is $7.625

Can Indians buy Hyperion DeFi, Inc. shares?

Yes, Indians can buy shares of Hyperion DeFi, Inc. (HYPD) on Vested. To buy Hyperion DeFi, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in HYPD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Hyperion DeFi, Inc. be purchased?

Yes, you can purchase fractional shares of Hyperion DeFi, Inc. (HYPD) via the Vested app. You can start investing in Hyperion DeFi, Inc. (HYPD) with a minimum investment of $1.

How to invest in Hyperion DeFi, Inc. shares from India?

You can invest in shares of Hyperion DeFi, Inc. (HYPD) via Vested in three simple steps:

  • Click on Sign Up or Invest in HYPD stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Hyperion DeFi, Inc. shares
What is Hyperion DeFi, Inc. 52-week high and low stock price?

The 52-week high price of Hyperion DeFi, Inc. (HYPD) is $75.2. The 52-week low price of Hyperion DeFi, Inc. (HYPD) is $0.85.

What is Hyperion DeFi, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Hyperion DeFi, Inc. (HYPD) is 0.00

What is the Market Cap of Hyperion DeFi, Inc.?

The market capitalization of Hyperion DeFi, Inc. (HYPD) is $30.54M

What is Hyperion DeFi, Inc.’s stock symbol?

The stock symbol (or ticker) of Hyperion DeFi, Inc. is HYPD

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top